March Biobullets
“You can’t use up creativity. The more you use, the more you have.” —Maya Angelou
Each day that goes by we’re seeing material progress against cancer. Like many deadly diseases of the past, we’re on the cusp of turning cancer into a chronic condition rather than the deadly killer it currently is.
Exciting news that a new checkpoint inhibitor has received FDA approval for melanoma. The first such approval since 2014, and certainly of relevance to many Aussies living with some form of melanoma.
One amino acid can have a huge impact: H3.1
How much does your company spend on R&D? How fast is that budget growing? In the highly competitive world of Pharma and Biotech, R&D spend is lifting considerably.
Here is Fast Company’s list of the 10 most innovative biotechs in 2022. Impossible to read this and not get buoyant about the prospects for the future.
Enjoy the reading, all the best to you and your families.